6836 BEE CAVE ROAD, AUSTIN, TX
Savara Inc. Stockholders Approve 2024 Omnibus Incentive Plan Amendment
Annual Report to Security Holders
Savara Inc. Enters Lease Agreement for New Headquarters Location
Material disclosure
Investor Presentation
Material Contracts, Other Events
Announces $75M Royalty Funding Agreement To Support The Potential Launch Of MOLBREEVI In Autoimmune Pulmonary Alveolar Proteinosis (Autoimmune PAP), Investor Presentation
Q2
Q1
FY 2025
Q3
Amended Annual Report
FY 2024
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Definitive Proxy Statement
Additional Proxy Materials
PRE 14A
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Amended Schedule 13G - Ownership Report
Correspondence